Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Natural History of Markers of Collagen Turnover in Patients With Early Diastolic Dysfunction and Impact of Eplerenone
JACC - Journal of the American College of Cardiology, 10/23/09
Mak GJ et al. – This study demonstrates progressive increases in markers of collagen turnover and inflammation in HFPSF with diastolic dysfunction. Despite high background utilization of renin–angiotensin–aldosterone modulators, eplerenone therapy prevents a progressive increase in pro–collagen type–III aminoterminal peptide and may have a role in management of this disease.
Today in Heart Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet - Early Online Publication, 11/18/09
Coenzyme Q10; an adjunctive therapy for congestive heart failure?
New Zealand Medical Journal, 11/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


